Avita Medical Announces Completion of Enrollment in ReCell Trial for Vitiligo

Avita Medical has completed enrollment of patients in a trial that will evaluate its ReCell for recurrence of abnormal skin pigmentation caused by vitiligo.
Yahoo! Finance